Clinical Trial Update: Benefit of Transcutaneous Auricular Vagus Nerve Stimulation in Improving Quality of Life in First Line Treatment of Ovarian Cancer: [Phase 3]

View source ↗

Summary

Phase 3 clinical trial is investigating whether transcutaneous auricular vagus nerve stimulation improves quality of life for patients receiving first-line chem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Transcutaneous Auricular Vagus Nerve Stimulation

Snippet

Sponsor: Centre Francois Baclesse | Conditions: Ovarian Carcinoma, First Line Chemotherapy | Phase 3 | Status: RECRUITING